Lincoln Pharmaceuticals Cash Flow Annual

Trade
BSE: 531633 | NSE: LINCOLN | ISIN: INE405C01035 | Sector: Biotechnology & Drugs
617.45 -0.05 (-0.01%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 122.24100.4895.9483.72
Depreciation/ Depletion 10.629.178.097.56
Non- Cash Items -27.75-8.56-5.88-2.46
Changesin Working Capital -41.90-61.83-22.01-19.55
Cashfrom Operating Activities 63.2239.2676.1369.27
Capital Expenditures -39.61-14.28-45.53-8.75
Other Investing Cash Flow Items Total -17.73-22.36-32.56-55.48
Cashfrom Investing Activities -57.34-36.64-78.08-64.23
Financing Cash Flow Items -1.27-1.35-1.04-1.19
Total Cash Dividends Paid -3.00-3.00-3.000.00
Issuance( Retirement)of Debt Net -0.90-0.141.48-4.55
Cashfrom Financing Activities -5.18-4.50-2.56-5.75
Net Changein Cash 0.70-1.88-4.50-0.70
Cash Interest Paid 1.271.351.041.19
Cash Taxes Paid 26.1529.6123.7019.49
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts